Axis 1

 Understanding the epidemiology of emerging and epidemic infectious diseases.

This axis involves designing and conducting primary research through cohort or case control studies and analyzing secondary data sources such as surveillance and clinical data to better understand the epidemiological profile of certain emerging and epidemic infectious diseases. Multi-level approaches are often used to consider both individual-level and area-level risk factors such as neighbourhood and broader scale environmental/ climatic risk factors. An important part of this research is to understand the significant drivers of disease at the population level and to identify vulnerable communities, which are often marginalized and poor. 

EnCORE Study and Sub-study

The EnCORE study is a collaborative research project between the University of Montreal and CHU Sainte-Justine which is estimating the proportion of SARS-CoV-2 infections (the virus that causes COVID-19) in children aged 2 to 17. The study is also examining children’s emotional and mental health. A cross-sectional phase of the study previously assessed SARS-CoV-2 infections among school and daycare staff.

The EnCORE immune sub-study is part of a pan-Canadian study examining children’s immune response to SRAS-CoV-2 infection and COVID-19 vaccines over time in children aged 2-11 years old.

Lyme disease case-control study

This study is one of the four pillars of the Canadian Lyme Disease Research Network (CLyDRN) and will help researchers gain important knowledge about what happens to people who get Lyme Disease (LD).

The purpose of this case-control study is to identify and estimate the significant determinants of LD risk and to assess differences in knowledge, attitudes, and practices (KAP) related to LD. We will also assess how LD risk, its determinants, and KAP change between different sites.